Kestra Medical Technologies, Ltd.

KMTS Healthcare Medical Instruments & Supplies

Kestra Medical Technologies, Ltd.’s revenue for fiscal 2026 (year ended April 2026) was $95.1 million, up 59.0% from fiscal 2025.

Revenue
+59.9%
EPS
−50.0%
Free cash flow
−17.8%
Total debt
+74.7%

Quarter to July 2026, against a year earlier

28.57 0.04 +0.14%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−12.1×
Dividend yield
—
F-score
4/9
Altman Z
3.87
Beneish M
1.67
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
ROE
(73.74%) (56.60%) (366.07%) 0.00%

+6 more TTM periods

ROA
(48.85%) (40.24%) (67.67%) (109.08%)
ROIC
(93.49%) (79.54%) (235.95%) (271.86%)
Return on Tangible Assets
(62.02%) (56.96%) (44.28%) (65.45%)
Average Days of Receivables
52.69 55.80 55.41 51.18
Free Cash Flow per Share
(2.10) (2.16) (2.15) (2.22)
Free Cash Flow
(123.06) (116.94) (120.01) (114.18)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 25 Oct 2026